He is known for his studies on investigating the regulatory mechanisms of Cancer Stem Cells during tumor metastasis.
His studies also involve the identification of signaling networks conferring resistance to current anti-cancer therapies.
His discovery of new anticancer agents holds a number of patents for the processes he has developed.
Council of Scientific and Industrial Research felicitated him with CSIR-Young Scientist Award (CSIR-YSA) in 2009.
[3] His major research focus remains to understand the critical regulatory biological mechanisms predisposed to the failure of current therapies, acquired resistance, and the onset of metastasis by exploring cellular catabolic machinery and regulatory networks of Cancer Stem Cells in subtypes of breast cancer.